News

One continuing challenge is the need to suppress transplant patients' immune systems to prevent their bodies from rejecting ...
Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...
The Dallas-based “de-extinction company” grabbed headlines this week with its announcement about resurrecting a creature that roamed the Americas more than ...
A new method can be used to identify factors involved in the specialization of naïve endothelial cells to tissue-specific endothelial cells.
The sci-fi fairytale of de-extinction may become a reality. Colossal Laboratories and Biosciences announced they have revived ...
However, exosomes from endothelial progenitor cells (EPCs) have not been tested in any stroke ... Briefly, culture media from EPC were collected, cell debris was removed by centrifugation, and media ...
Colossal pioneered a cloning method using endothelial progenitor cells (EPCs) extracted from gray wolf blood—a less invasive alternative to traditional tissue sampling. These cells were edited with ...
1 Laboratory of Regenerative Medicine, Medical University of Warsaw, Warsaw, Poland 2 Stem Cell ... derived stem cells: mononuclear cells (MNCs), very small embryonic-like stem cells (VSELs), ...
Startup Colossal Biosciences has edited the DNA of a gray wolf to produce what it says is a de-extincted animal. Does that ...
“For me,” James says, “it was sort ... known as endothelial progenitor cells (EPCs), which form the lining of blood vessels. The scientists then rewrote the 14 key genes in the cell ...
We previously reported that Notch1 activation in committed basal cells triggers a basal-to-luminal cell fate switch in the mouse mammary gland. Here, we report conservation of this mechanism and found ...